King Abdulaziz University Research Earns Global Leadership in Oncology

King Abdulaziz University's achievements in scientific research resulted in the selection of faculty member and therapeutic oncology consultant Professor Atlal Abusanad as the first representative from the Gulf region to be named a global leader in oncology. She was chosen for the prestigious Leadership Development Program of the American Society of Clinical Oncology (ASCO), the world's leading organization in the field, in recognition of her contributions to advancing oncology research and care.
 This recognition reinforces King Abdulaziz University's standing in international academic forums and highlights Saudi Arabia's contributions to the field of oncology. It also introduces the global medical community to local research in breast cancer, personalized medicine, and the well-being of oncologists.
 ASCO's competitive leadership program, the most prestigious of its kind globally, is designed to cultivate medical leadership over the course of a full year. It selects a limited number of highly qualified participants and trains them in leadership strategies and institutional planning, including strategic projects aimed at shaping the future of global oncology. The program seeks to prepare leaders who can make a positive impact in cancer care and strengthen the international presence of their institutions.
 Oncology services at King Abdulaziz University Hospital provide comprehensive care to cancer patients, supported by world-class medical staff and specialized tumor boards, including breast and gastrointestinal cancers. The hospital develops personalized treatment plans for each patient and actively contributes to medical training and scientific research in collaboration with specialized research centers.